By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

LungRx Inc. 



Satellite Beach  Florida  32937  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
LungRx Inc. (UTHR) and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction 2/10/2010 8:49:11 AM
Aradigm Corporation (ARDM) Completes Study of Inhaled Treprostinil with AERx(R) Inhaler; Lung Rx Makes First Milestone Payment to Aradigm 11/10/2008 8:15:34 AM
Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration; First Presentation of Full Data Set from the TRIUMPH-1 Trial of Inhaled Treprostinil 5/22/2008 11:13:16 AM
Aradigm Corporation (ARDM) and LungRx Inc. (UTHR) Agree to Develop AERx Essence(R) Technology for Use in Pulmonary Arterial Hypertension 9/5/2007 12:15:14 PM
LungRx Inc. (UTHR) TRIUMPH Trial Enrollment to Close 7/11/2007 9:48:43 AM
Exclusive License Agreement for Modified Release Beraprost Assumed and Restated by LungRx Inc. (UTHR) 3/28/2007 11:40:58 AM
LungRx Inc. (UTHR) Release: Results Of Inhaled Treprostinil Controlled Pilot Studies Reported In The Journal Of The American College Of Cardiology 2/8/2007 12:49:06 PM
LungRx Inc. (UTHR) Release: Results Of Inhaled Treprostinil Study Reported In The Journal Of The American College Of Cardiology 10/10/2006 12:45:48 PM
LungRx Inc., (UTHR) An Emerging Biotech Now Has The Capabilities Of Large Pharma, Without The Costly Infrastructure And Employees Usually Needed10/19/2005 5:08:55 PM
//-->